ABO
Basic information
Region (hg38): 9:133233278-133276024
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Blood group, ABO system | BG | Hematologic | Variants associated with a blood group may be important in specific situations (eg, related to transfusion) | Hematologic | 4014172; 2647864; 2333095; 1303212; 1572640; 8075282; 7772867; 9099833; 11520811; 12014997; 12829588; 17959777 |
ClinVar
This is a list of variants' phenotypes submitted to
- - (13 variants)
- Three Vessel Coronary Disease (9 variants)
- ABO blood group system (8 variants)
- not provided (4 variants)
- Severely weakened expression of A on erythrocytes (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 5 | |||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 8 | |||||
Total | 0 | 0 | 1 | 1 | 13 |
Variants in ABO
This is a list of pathogenic ClinVar variants found in the ABO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-133255669-CG-C | ABO blood group system | Affects (Aug 31, 1992) | ||
9-133255742-A-G | - | no classification for the single variant (-) | ||
9-133255801-C-T | - | no classification for the single variant (-) | ||
9-133255905-C-T | ABO-related disorder | Likely benign (Dec 17, 2020) | ||
9-133255928-C-G | Three Vessel Coronary Disease | Benign (-) | ||
9-133255935-G-T | - | no classification for the single variant (-) | ||
9-133255963-G-A | ABO-related disorder | Likely benign (Dec 17, 2020) | ||
9-133256028-C-T | - | no classification for the single variant (-) | ||
9-133256031-G-C | ABO blood group system | Affects (Aug 27, 1999) | ||
9-133256074-G-A | - | no classification for the single variant (-) | ||
9-133256085-A-T | Three Vessel Coronary Disease | Benign (-) | ||
9-133256202-C-T | Likely benign (Apr 01, 2023) | |||
9-133256205-G-C | - | no classification for the single variant (-) | ||
9-133256205-G-G | - | no classification for the single variant (-) | ||
9-133256234-GT-G | - | no classification for the single variant (-) | ||
9-133256264-G-A | - | no classification for the single variant (-) | ||
9-133256963-T-C | Three Vessel Coronary Disease | Benign (-) | ||
9-133257246-A-G | Three Vessel Coronary Disease | Benign (-) | ||
9-133257486-T-C | - | no classification for the single variant (-) | ||
9-133257486-T-G | - | no classification for the single variant (-) | ||
9-133258116-G-A | Benign (Dec 31, 2019) | |||
9-133259717-G-T | Three Vessel Coronary Disease | Benign (-) | ||
9-133259834-C-C | Benign (Dec 19, 2019) | |||
9-133261366-A-AC | ABO blood group system • Severely weakened expression of A on erythrocytes | Benign; Affects (Jul 12, 2023) | ||
9-133261367-C-A | Benign (Dec 31, 2019) |
GnomAD
Source:
dbNSFP
Source:
- Function
- FUNCTION: This protein is the basis of the ABO blood group system. The histo-blood group ABO involves three carbohydrate antigens: A, B, and H. A, B, and AB individuals express a glycosyltransferase activity that converts the H antigen to the A antigen (by addition of UDP-GalNAc) or to the B antigen (by addition of UDP-Gal), whereas O individuals lack such activity.;
- Pathway
- Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human);Globo Sphingolipid Metabolism;Hematopoietic Stem Cell Differentiation;Glycosphingolipid biosynthesis - lactoseries;Glycosphingolipid biosynthesis - neolactoseries
(Consensus)
Recessive Scores
- pRec
- 0.829
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- hipred_score
- ghis
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.186
Mouse Genome Informatics
- Gene name
- Abo
- Phenotype
Gene ontology
- Biological process
- carbohydrate metabolic process;protein glycosylation;lipid glycosylation
- Cellular component
- extracellular region;Golgi apparatus;integral component of membrane;vesicle;Golgi cisterna membrane
- Molecular function
- nucleotide binding;antigen binding;glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity;fucosylgalactoside 3-alpha-galactosyltransferase activity;transferase activity, transferring glycosyl groups;manganese ion binding